The Vanderbilt-Ingram Cancer Center and Richard S. Reynolds Foundation announce a new funding opportunity for breast cancer studies proposing translational innovations. This program aims to support investigators who are exploring dynamic and innovative ways to help empower patients in their care; seek novel approaches to determine risk; or provide prevention and treatment strategies, patient engagement and empowerment, and overall well-being.
Applications can be in any area of research or patient care but should follow the mission of unique, innovative ideas or laboratory research that is poised to be translated into the clinic but requires seed funding for initial clinical proof of principle. High-risk/high-reward ideas are encouraged, but such applications should describe a “fast-to-fail” strategy that would enable a go/no-go decision at the end of the one-year term of the award.
Qualified VU/VUMC/VICC faculty, including those with adjunct appointments (e.g., Meharry Medical Center faculty), are eligible. Junior faculty, including instructors and research assistants/associate professors, are also eligible but the application must include a senior mentor as part of the research team.
The goal of these funds is to support a multidisciplinary research project that has the potential to change the current paradigm of breast cancer prevention, diagnosis or therapy. Thus, applications are required to include at least two investigators from different academic divisions/departments.
Application instructions and a blank application template can be found here.
Please submit a single PDF containing all required application documents by midnight on Saturday, Sept. 26, 2020.
If you have questions, please contact Jennifer Whisenant.